LEMAITRE VASCULAR INC 10-Q

Item 5. Other Information Rule 10b5-1 and non-Rule 10b5-1 trading arrangements During the fiscal quarter ended June 30, 2024, none of our directors or officers informed us of the adoption, modification or termination of a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as those terms are defined in Regulation S-K, Item 408. 30 Table of Contents Item 6. Exhibits Incorporated by Reference Exhibit Number Exhibit Description Form Date Number Filed Herewith 3.1 Amended and Restated By-laws of the Registrant S-1/A 5/26/06 001-33092 3.2 Second Amended and Restated Certificate of Incorporation of the Registrant 10-K 3/29/10 001-33092 3.3 Amendment to Second Amended and Restated Certificate of Incorporation of the Registrant 8-K 6/5/12 001-33092 10.1 LeMaitre Vascular, Inc. Fourth Amendment and Restated 2006 Stock Option and Incentive Plan 8-K 6/3/24 001-33092 31.1 Certification of Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15 d-14(a). X 31.2 Certification of Chief Financial Officer, as required by Rule 13a-14(a) or Rule 15d-14(a). X 32.1 Certification by the Chief Executive Officer, as required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. § 1350).* X 32.2 Certification by the Chief Financial Officer, as required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. § 1350).* X 101.INS Inline XBRL Instance Document. X 101.SCH Inline XBRL Taxonomy Extension Schema Document. X 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document. X 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document. X 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document. X 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document. X 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). X † Indicates a management contract or any compensatory plan, contract, or arrangement. * The certifications attached as Exhibit 32.1 and Exhibit 32.2 that accompany this Quarterly Report on Form 10-Q, are not deemed filed with the SEC and are not to be incorporated by reference into any filing of LeMaitre Vascular, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing. 31 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on August 8, 2024. LEMAITRE VASCULAR, INC. /s/ George W. LeMaitre George W. LeMaitre Chairman and Chief Executive Officer /s/ Joseph P. Pellegrino, Jr. Joseph P. Pellegrino, Jr. Chief Financial Officer and Director 32